ADP EyeCare
  • ADP-EyeCare
    • ADP-EyeCare – An Introduction
    • Mr Andrew D Price FBDO(Hons)CL, COA - Portfolio
    • Mrs Elizabeth Ralph FBDO CL - Portfolio
    • Mrs Vanessa Uden FBDO CL - Portfolio
    • Mr Ganeshbabu Mahalingam MPhil PhD FCOptom FBCLA ProfHigherGlaucoma - Portfolio
  • Dry/Watery Eye Clinic
    • Dry Eye/Watery Eye Clinic Brochure
    • Dry Eye Drops – The What and the How
    • Dry or Watery Eyes – In-Practice/Clinic Professional Treatments
    • Eye Allergy – Our Expert Advice Can Help
    • Dry/Watery Eye FAQs
    • Private Referral for Dry/Watery Eye/Blepharitis Assessment to Mr Andrew D Price
    • Private Referral for Dry/Watery Eye/Blepharitis Assessment to Mrs Elizabeth Ralph
    • Private Referral for Dry/Watery Eye/Blepharitis Assessment to Mr Ganeshbabu Mahalingam
    • Dry Eye Clinic Video
    • Dry/Watery Eye Videos
  • Contact Lens Clinic
    • The Joy of Contact Lenses
    • Contact Lens Clinic Brochure
    • Brits put their eyesight at risk!
    • Contact Lenses FAQ
    • Private Referral for Contact Lens Assessment/After-Care to Mr Andrew D Price
    • Private Referral for Contact Lens Assessment/After-Care to Mrs Elizabeth Ralph
    • Private Referral for Contact Lens Assessment/After-Care to Mrs Vanessa Uden
    • Private Referral for Contact Lens Assessment/After-Care to Mr Ganeshbabu Mahalingam
    • Private Referral for Contact Lens Assessment/After-Care to Mr Colin Jones
    • Private Referral for Contact Lens Assessment/After-Care to Mohamed Ayyaz Kasmani
  • Clinical Trials - Can You Help?
  • Also Interesting!
    • Are you one of the 72% of people who are not using their eye drops safely or effectively?
    • Hand Hygiene – a Science Behind It!
    • How the Human Eye Works
    • State of the Art Eye Mapping and Tear Film Analysis
    • Make eye drops part of your Ramadan routine
  • Very very specialist services!
    • About ChromaGen™ Contact Lenses for Colour Vision Deficiency (CVD)
    • Punctal Occlusion – a proven treatment for Dry Eye and Contact Lens Discomfort
    • Ortho-K – Overnight Vision Correction
    • Paediatric Myopia Management/Control
    • Adult Myopia Management/Control
    • Soft for comfort with crisp vision - Hybrid Contact Lenses!
  • Remote Consultation
  • Downloads
  • The Blog!

  • Dry/Watery Eye – how I can help?
    The eyes surface and tears are complex – trial and error is not the way!
  • Cause of Contact Lens Discomfort
    Specialist exam techniques can show how contact lens wear can be successful
  • Lid conditions need microscopic examination
    It is not possible to diagnose and successful treat without a specialist exam
  • Short-sighted eyes grow longer!
    Is your child suitable for Myopia (Progression) Management?
  • Colour vision enhancement
    Specialist contact lenses may give improved colour vision discrimination
  • Ortho-K - clear vision without the need for surgery, glasses or contact lenses
    Ortho-K - clear vision without the need for surgery, glasses or contact lenses
  • Latest technology for diagnosis
    Specialist technology can now identify reasons for dry eye/contact lens discomfort
  • Latest technology for treatment
    Specialist technology can now treat dry eye/contact lens discomfort
Error

Over-Night Refractive Treatment

Dry Eye Clinic Video
Stop Press: Over-Night Refractive Treatment is now available for long, short sight, near prescriptions and post refractive surgery - watch this video. 

Dry Eye Clinic Video

Dry Eye Clinic Video
Why a clinic appointment is so important
watch this video

Latest News

LATEST NEWS! This column will carry the latest news for ADP-EyeCare patients and/or prospective patients. 

18/05/2025: On May 15, 2025, Contamac Solutions, Inc. announced a voluntary product recall in the United States for lots HFH, HGC, HGI, HGN, HKF, HKK of Nutrifill, a preservative-free contact lens insertion solution. Go to https://contamacsolutions.com/pages/public-notice-recall to read more. 

13/05/2025: Device safety information and medicines recall/notification. Class 4 Medicines Notification, Chemidex Pharma Ltd, Various Products, EL(25)A/21. Page summary: Chemidex Pharma Ltd has informed the MHRA that the Patient Information Leaflet (PIL) in their topical steroid products does not contain all the required safety information. Cartons for the products/batches listed are missing side effect information related to Visual Disturbances.

13/05/2025: 75,000+ Cases of Eye Care Products Recalled Nationwide (USA) Over Sterility Concerns, FDA Says. Go to Health to read more. 

08/05/2025: Company initiated and FDA Enforcement recall of 34,000 contact lenses in February/March 2025. Lens names that may be known to UK ECPs and patients are 'MyDay Toric' and 'Specsavers Easyvision Linarial Toric'. See The Healthy and FDA Enforcement Report. 

08/05/2025: MHRA Class 4 Medicines Defect Notification: Chloramphenicol 1% w/w Eye Ointment, Blumont Pharma Limited, EL(25)A/20.

02/05/2025: Another testmonial added to the ADP Portfolio

23/04/2025: Andrew D Price - Contributing CPD Author to 'Optician' Journal.

24/12/2024: Recall Alert - "FOR IMMEDIATE RELEASE – 12/21/2024 – Fort Worth, Texas. Alcon Laboratories is voluntarily recalling one (1) lot of Systane Lubricant Eye Drops Ultra PF, Single Vials On-the-Go, 25 count (Lot 10101) to the consumer level. Alcon evaluated a consumer complaint of foreign material observed inside a sealed single use vial and determined the material to be fungal in nature". Go to Company Announcement for further information. 

15/11/2024: Beth Ralph now 'Holder of Omnigen Amniotic Membrane Training Certificate'.

07/11/2024: Warning. US FDA publish warning letter to 'Fancy Drops Beauty LLC' regarding colour changing eye drops readily available via UK internet supply. 

27/09/2024: Recall Alert  - The Healthy Magazine reports - "The major pharmaceutical company Allergan, owned by AbbVie, has issued a recall of two eye ointments under the Refresh brand that are targeted to treat dry eye".

25/09/2024: 'Sensitive cilia - eye lashes in health and disease', a new entry in The Blog.

08/09/2024: Mrs Badfield's testimonial added to Andrew D Price Portfolio.  

 

 

 

 

 

  1. You are here:  
  2. Home
  3. Clinical Trials - Can You Help?

Clinical Trials - Can You Help?

Details
Published: 22 September 2019

Share this article on
Whatsapp

Clinical trials - recruiting subjects

The ADP Consultancy conducts clinical trials for the purpose of increasing our knowledge in the field of eye care. We are happy to receive communication from other ECPs/HCPs on referrals for the trials and returning patients to you for continuing care with reports on each patient. We are also happy to pubish details on clinical trials being undertaken elsewhere.

Meibomian gland disease - Intense Pulsed Light & Low Level Light Therapies

09/02/2024: Researchers from Aston Optometry School are assessing how light-based therapies, known to be effective for dry eye disease treatment, work to improve the health of our oil glands in our eyelids. These include intense pulsed light therapy (IPL) and low-level light therapy (LLLT).

We are seeking adult volunteer participants aged 18 and over who are suffering from a specific form of dry eye disease where the oil glands in your eyelids are not working properly (called Meibomian gland disease).

You will not be able to participate if you are pregnant, wore contact lenses in the past 2 weeks or will be during the study, have only 1 eye, have systemic conditions that can cause dry eye disease such as diabetes or Sjögren’s syndrome, contraindicated for IPL treatment (e.g. have photosensitive epilepsy, used photosensitising medication in the past 3 months, have tattoos, implants, electrical or acoustic prosthetics, semi-permanent make-up, pigmented lesions or skin cancers in the treatment area, have pacemakers or have darker skin tone: Fitzpatrick skin type V or VI), had facial or ocular light therapies in the past 6 months, or had a history of ocular surgery or corneal infections.

You will attend a total of 6 visits (4 treatment visits provided for free 2 to 3 weeks apart, and then 2 follow-up visits 2 weeks and 3 months after the final treatment visit). If you are eligible and suitable for treatment, one of your eyes will be randomised to receiving both IPL and LLLT, and the other eye will receive LLLT alone so that we can compare how these treatments work.

Your blood flow in the eyelids and nerves on the surface of the eyes will also be analysed using sophisticated, non-invasive instruments during the first and follow-up visits. Each visit lasts about 1.5 hours. If you would like to hear more, or are interested in participating, please contact Dr Jeremy Chiang (This email address is being protected from spambots. You need JavaScript enabled to view it.).

Contact Lens Discomfort Trial - at-home Treatment

20/07/2021: The ADP Consultancy conducts clinical trials for the purpose of increasing our knowledge in the field of eye care.  We hope to have a trial under way soon looking at-home treatments for contact lens discomfort, if you think you would like to find out more about how you might help, or may be interested in future trials and live within traveling distance of Nantwich. We are looking for subjects who find their contact lenses are not as comfortable as they would like, especially at the end of the day. The trial does not involve changing lenses or solutions. The object of the clinical trial is to determine if a specific at-home treatment reduces contact lens discomfort. Subjects will be paid to be part of the trial and provided with all treatment products free-of-charge. If you would like to know more about this trial please email This email address is being protected from spambots. You need JavaScript enabled to view it. 29/05/2022 Update: This trial has now closed 

Prevalance of Meibomian gland loss in a population

Not so much a clinical trial, but certainly reserach, as part of the normal eye exam (sight test) provided by S W & C Jackson Opticians of Nantwich, Meibomian gland screening with grading will be included at no extra charge. As well as offering more information to individual patients on their eye health it will generate fully anonymised data on the the prevelance and grading of Meibomian gland loss in both symptomatic and non-symptomatic patients. It is anticipated this will generate data on hundreds of eyes in a relatively short space of time that can help improve care of dry eye and potential dry eye patients. If you are a patient who would like to have this screening included in your next general eye exam at no extra charge email This email address is being protected from spambots. You need JavaScript enabled to view it. or if you are a Health Care Professional or in the eye care industry and are interested in the results as they contunue to accrue email This email address is being protected from spambots. You need JavaScript enabled to view it. 29/05/2022 Update: This research has now closed 

DOORS Press Release

download Dry Eye Study Flyer

A new health study is to be launched in a bid to help millions who suffer from ‘dry eye’.
One in four of us will suffer from the debilitating condition with symptoms ranging from sore eyes through to short-term blurred vision.
Now experts based in Birmingham and Nottingham are looking for people to take part in the study, wearing a special contact lens for under 2 weeks, which could lead to longer term relief.
Volunteers are being sought for the research which is being conducted by Aston University’s Eye Clinic in collaboration with Nottingham’s NuVision Biotherapies, a company formed with backing of the University of Nottingham.
The study follows the development of an eyesight-saving product, Omnigen, derived from human amniotic membrane donated from caesarean sections. Up until recently it could only be applied surgically but NuVision have created OmniLenz.
This bespoke contact lens allows the surgery-free application of Omnigen. Such a simple, 5-minute procedure enables eyecare professions to treat ocular surface diseases, as simply as applying a contact lens, early and more effectively without the need for surgery.
Professor James Wolffsohn, principle investigator of the study, said: “Dry eye can be a severe, chronic and debilitating disease. Amniotic membrane has shown great promise in its management, but retention on the eye is required. We want to see how we can help people with dry eye by applying this lens.
“Omnigen is already successfully used throughout the NHS and the study aims to demonstrate that the wound healing benefits of Omnigen are easily transferable to those suffering and living with dry eye disease.”
This trial is designed as a prospective, double-arm, investigational randomised study to examine the change in dry eye disease symptoms and pathology following the in-clinic OmniLenz transplantation of Omnigen for patients suffering from moderate to severe dry eye disease.
Founder and Chief Scientific Officer of NuVision, Dr. Andrew Hopkinson, said: “Amniotic membrane has clinically proven wound healing capability which historically has been reserved for severe surgical situations. Through the innovation of OmniLenz application of Omnigen in an out-patient setting, NuVision is already helping to treat patients with severe ocular surface injuries. However, this clinical trial now aims to demonstrate a benefit to those suffering from dry eye disease.”
NuVision received support from the INSTILS project – part-funded through the European Regional Development Fund (ERDF) and delivered by Medilink East Midlands. Thanks to INSTILS support, NuVision received an Innovation Support Grant, to the value of £12,920, which will allow them to undertake this study with Aston University, accelerating the clinical trial process and bringing NuVision’s novel approach to market faster than would have otherwise been possible.
Darren Clark, Chief Executive of Medilink East Midlands, said: “NuVision has a truly innovative and outstanding approach to treating dry eye disease. I am confident that the help we’ve given to them, both in terms of the Innovation Support Grant and the dedicated time and effort that one of our Innovation Advisers has invested in them, will make their treatment available quicker, improving outcomes for patients worldwide.”
If you are interested in taking part in the study, please contact This email address is being protected from spambots. You need JavaScript enabled to view it. or call +44 (0) 121 204 4400 to arrange a consultation.

Contact Lens Discomfort Trial - In-Practice Treatment

We are looking for subjects who find their contact lenses are not as comfortable as they would like, especially at the end of the day. The trial does not involve changing lenses or solutions but rather treating the eye's vital meibomian glands that secrete protective oils into the tears. The object of the clinical trial is to determine if, and for how long, a one-off in-practice treatment reduces contact lens discomfort. If you would like to know more about this trial please and could attend the clinics in Nantwich, Southport or Leyland please email This email address is being protected from spambots. You need JavaScript enabled to view it.  29/05/2021 Update: This trial has now closed 

Made-to-Order Multifocal Contact Lens Trial

Would a 'tailor made' made-to-order multifocal lens perfor better than the equivalant widely prescribed off-the-shelf alternative? A few statistically signifianct differences were found for visual acuity and subjective vision and the overall performance of 'tailor made' lens was much better than off-the-shelf alternative. These aspects could be leveraged in a marketing campaign among contact lens practices seeking to have better overall success with multifocal soft conact lenses. 08/01/2017 Update: This trial has now completed and closed with report issued to sponsor. 

Multi-Focal Contact Lens Trial (two separate trials)

We are looking for subjects who are over 42 and require different prescriptions for distance and near, bifocal/varifocal glasses, two pairs of glasses, removes distance glasses to read, glasses over contact lenses to read or monovision contact lenses. The object of the clinical trial is to determine if vision with contact lenses changes over a time period. Subjects who complete the clinical trial and are successful with the sponsor's lenses will be offered 3 months lenses free-of-charge (approx value £150.00). The subjects would be prescribed one or two pairs of lenses to wear for a week, normally three to four practice visits will be required. 05/05/2017 Update: Both of these trials has now completed and closed with report issued to sponsor.  

Contact Lens Discomfort Trial

We are looking for subjects who find their contact lenses are not as comfortable as they would like, especially at the end of the day. The trial does not involve changing lenses or solutions but rather using a means to retain more tears on the eye surface. the object of the clinical trial is to determine if retaining more tears on the eye surface reduces contact lens discomfort. Subjects who complete the clinical trial will be given £100.00 practice credit. 23/12/2016 Update: This trial has now completed and closed. Interim results have been published. If you are interested in the interim results and what it may mean to you as a Contact Lens wearer email This email address is being protected from spambots. You need JavaScript enabled to view it. 24/03/2017 Update: This trial has now completed and closed with report issued to sponsor. A clinical trials poster was presented at the BCLA CC in 2017.

Contact Lens Uncorrected Cyl Trial

We are looking for subjects (both CL and non-CL wearers) between 18 and 40 who have cylinder corrections up to and including -1.00 at any axis with sphere powers obtainable in daily disposable lenses. The subjects will wear both a toric and a spherical lens on two different occasions with the aim of determining if their is a objective and/or subjective visual benefit to correcting small cyls with toric lenses. Subjects who complete the trial will be offered £50 payment and £50 practice credit. For further information email This email address is being protected from spambots. You need JavaScript enabled to view it. 06/03/2018 Update: This trial has now completed and closed with report issued to sponsor. A clinical trials poster was presented at Optrafair in 2018. 

Share this article on
Whatsapp

  • Privacy Policy
  • Disclaimer

Copyright © 2019 - 2022 ADP Eye Care. All rights reserved.